Drug Information

Drug General Information
Drug ID
D0M1ON
Former ID
DNCL002076
Drug Name
SHP-141
Indication Cutaneous T-cell lymphoma [ICD9: 202.1, 202.2; ICD10:C84.0, C84.1] Phase 1 [523985]
Company
Leukemia & Lymphoma Society; Shape Pharmaceuticals
Target and Pathway
Target(s) Histone deacetylase Target Info Modulator [550476]
References
Ref 523985ClinicalTrials.gov (NCT01646567) SHP-141C in Plaque Type Psoriasis. U.S. National Institutes of Health.
Ref 550476National Cancer Institute Drug Dictionary (drug id 703816).

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.